Suivi thérapeutique pharmacologique de la quinine

2010 Société de Pathologie Infectieuse de Langue Française, 2008, Management and prevention of imported Plasmodium falciparum malaria (Revision 2007 of the 1999 Consensus Conference), Med Mal Infect, 38, 68 Slater, 1992, Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites, Nature, 355, 167, 10.1038/355167a0 Egan, 1994, Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment), FEBS Lett, 352, 54, 10.1016/0014-5793(94)00921-X Foley, 1997, Quinoline antimalarials: mechanisms of action and resistance, Int J Parasitol, 27, 231, 10.1016/S0020-7519(96)00152-X Salako, 1992, Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans, Eur J Clin Pharmacol, 42, 171, 10.1007/BF00278479 Paintaud, 1993, The reproducibility of quinine bioavailability, Br J Clin Pharmacol, 35, 305, 10.1111/j.1365-2125.1993.tb05698.x Pasvol, 1991, Quinine treatment of severe falciparum malaria in african children: a randomized comparison of three regimens, Am J Trop Med Hyg, 45, 702, 10.4269/ajtmh.1991.45.702 Pukrittayakamee, 2003, Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria, Antimicrob Agents Chemother, 47, 3458, 10.1128/AAC.47.11.3458-3463.2003 Supanaranond, 1991, Disposition of oral quinine in acute falciparum malaria, Eur J Clin Pharmacol, 40, 49, 10.1007/BF00315138 White, 1982, Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria, Am J Med, 73, 564, 10.1016/0002-9343(82)90337-0 Krishna, 1996, Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications, Clin Pharmacokinet, 30, 263, 10.2165/00003088-199630040-00002 Silamut, 1991, α1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria, Br J Clin Pharmacol, 32, 311, 10.1111/j.1365-2125.1991.tb03904.x Mansor, 1991, Effect of Plasmodium falciparum malaria infection on the plasma concentration of α1-acid glycoprotein and the binding of quinine in Malawian children, Br J Clin Pharmacol, 32, 317, 10.1111/j.1365-2125.1991.tb03905.x White, 1983, Red cell quinine concentrations in falciparum malaria, Am J Trop Med Hyg, 32, 456, 10.4269/ajtmh.1983.32.456 Brodie, 1951, Metabolic products of the cinchona alkaloids in human urine, J Biol Chem, 188, 567, 10.1016/S0021-9258(19)77729-1 Zhang, 1997, Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine, Br J Clin Pharmacol, 43, 245, 10.1046/j.1365-2125.1997.00556.x Mirghani, 1999, The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo, Clin Pharmacol Ther, 66, 454, 10.1016/S0009-9236(99)70008-1 Mirghani, 2002, Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro; 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway, Drug Metab Dispos, 30, 1368, 10.1124/dmd.30.12.1368 Liddle, 1981, Identification of new urinary metabolites in man of quinine using methane chemical ionization gas chromatography-mass spectrometry, Xenobiotica, 11, 81, 10.3109/00498258109045277 Wanwimolruk, 1995, Metabolism of quinine in man: identification of a major metabolite, and effects of smoking and rifampicin pretreatment, J Pharm Pharmacol, 47, 957, 10.1111/j.2042-7158.1995.tb03277.x Mirghani, 2003, Metabolism and elimination of quinine in healthy volunteers, Eur J CLin Pharmacol, 59, 423, 10.1007/s00228-003-0637-8 Pukrittayakamee, 1997, A study of the factors affecting metabolic clearance of quinine malaria, Eur J Clin Pharmacol, 52, 487, 10.1007/s002280050323 Thomas, 1984, Forced acid diuresis and stellate ganglion block in the treatment of quinine poisoning, Anaesthesia, 39, 257, 10.1111/j.1365-2044.1984.tb07239.x Bateman, 1985, Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination, Q J Med, 54, 125 Mansor, 1990, The safety and kinetics of intramuscular quinine in Malawian children with moderately severe falciparum malaria, Trans R Soc Trop Med Hyg, 84, 482, 10.1016/0035-9203(90)90007-2 Flanagan, 2006, Quinine levels revisited: the value of routine drug level monitoring for those on parenteral therapy, Acta Tropica, 97, 233, 10.1016/j.actatropica.2005.11.006 White, 1983, Quinine loading dose in cerebral malaria, Am J Trop Med Hyg, 32, 1, 10.4269/ajtmh.1983.32.1 WHO, 2000, Severe falciparum malaria, 3rd edition, Trans R Soc Trop Med Hyg, 94, 1 Mapaba, 1995, Susceptibility of Plasmodium falciparum to quinine in vitro: effects of drug concentrations and time of exposure, Trans R Soc Trop Med Hyg, 89, 85, 10.1016/0035-9203(95)90671-1 Le Jouan, 2005, Quinine pharmacokinetics and pharmacodynamics in children with malaria caused by Plasmodium falciparum, Antimicrob Agents Chemother, 49, 3658, 10.1128/AAC.49.9.3658-3662.2005 Vieira, 2001, Drug monitoring of quinine in men with nonsevere falciparum malaria: study in the amazon region of Brazil, Ther Drug Monit, 23, 612, 10.1097/00007691-200112000-00003 Alvan, 1991, Hearing impairment related to plasma quinine concentration in healthy volunteers, Br J Clin Pharmacol, 31, 409, 10.1111/j.1365-2125.1991.tb05554.x Paintaud, 1994, The concentration-effect relationship of quinine-induced hearing impairment, Clin Pharmacol Ther, 55, 317, 10.1038/clpt.1994.32 Claessen, 1998, Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria, Trop Med Int Health, 3, 483, 10.1046/j.1365-3156.1998.00252.x White, 1983, Quinine and quinidine: a comparison of EKG effects during the treatment of malaria, J Cardiovasc Pharmacol, 5, 173, 10.1097/00005344-198303000-00001 White, 1983, Severe hypoglycemia and hyperinsulinemia in falciparum malaria, N Engl J Med, 309, 61, 10.1056/NEJM198307143090201 Davis, 1994, Glucose turnover in pregnant women with acute malaria, Clin Sci, 86, 83, 10.1042/cs0860083 Agbenyega, 2000, Glucose and lactate kinetics in children with severe malaria, J Clin Endocrinol Metab, 85, 1569 Davis, 2002, Glucose and lactate turnover in adults with falciparum malaria: effect of complications and antimalarial therapy, Trans R Soc Trop Med Hyg, 96, 411, 10.1016/S0035-9203(02)90377-9 Murad, 2009, Drug-induced hypoglycemia: a systematic review, J Clin Endocrinol Metab, 94, 741, 10.1210/jc.2008-1416 Sabchareon, 1982, Serum quinine concentrations following the initial dose in children with falciparum malaria, Southeast Asian J Trop Med Public Health, 13, 556 Hall, 1975, Quinine dosage and serum levels in falciparum malaria. Annual report of SEATO Medical Research Laboratories, SEATO, 241 Shann, 1985, Pharmacokinetics of quinine in children, J Pediatr, 106, 506, 10.1016/S0022-3476(85)80692-2 Rimchala, 1996, Pharmacokinetics of quinine in patients with chronic renal failure, Eur J Clin Pharmacol, 49, 497, 10.1007/BF00195937 Newton, 1999, Pharmacokinetics of quinine and 3-hydroxyquinine in severe falciparum malaria, Trans R Soc Trop Med Hyg, 93, 69, 10.1016/S0035-9203(99)90184-0 Karbwang, 1993, The pharmacokinetics of quinine in patients with hepatitis, Br J Clin Pharmacol, 35, 444, 10.1111/j.1365-2125.1993.tb04165.x Orlando, 2009, Irreversible CYP3A inhibition accompanied by plasma protein–binding displacement: a comparative analysis in subjects with normal and impaired liver function, Clin Pharmacol Ther, 85, 319, 10.1038/clpt.2008.216 Phillips, 1986, Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria, Br J Clin Pharmacol, 21, 677, 10.1111/j.1365-2125.1986.tb05233.x Abdelrahim, 2007, Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria, J Clin Pharm Ther, 32, 15, 10.1111/j.1365-2710.2007.00788.x Mirghani, 2010, Effects of Plasmodium falciparum infection on the pharmacokinetics of quinine and its metabolites in pregnant and non-pregnant Sudanese women, Eur J Clin Pharmacol, 66, 1229, 10.1007/s00228-010-0877-3 Lefèvre, 2002, Interaction between arthemeterlumefantrine (Riamet) and quinine in healthy subjects, J Clin Pharmacol, 42, 1147, 10.1177/009127002401382632 Couet, 1991, Pharmacokinetics of quinine and doxycycline in patients with acute falciparum malaria: a study in Africa, Ther Drug Monit, 13, 496, 10.1097/00007691-199111000-00005 Wandell, 1980, Effect of quinine on digoxin kinetics, Clin Pharmacol Ther, 28, 425, 10.1038/clpt.1980.183 Zhao, 1999, A further interaction study of quinine with clinically important drugs by human liver microsomes: determinations of inhibition constant (Ki) and type of inhibition, Eur J Drug Metab Pharmacokinet, 24, 272, 10.1007/BF03190031 Sousa, 2008, Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs, J Antimicrob Chemother, 62, 872, 10.1093/jac/dkn330 Wanwimolruk, 1995, Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man, Br J Clin Pharmacol, 40, 87, 10.1111/j.1365-2125.1995.tb04541.x Pukrittayakamee, 2003, Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria, Antimicrob Agents Chemother, 47, 1509, 10.1128/AAC.47.5.1509-1513.2003 Soyinka, 2010, Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration, Br J Clin Pharmacol, 69, 262, 10.1111/j.1365-2125.2009.03566.x Soyinka, 2009, Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers, J Pharm Pharmacol, 61, 439, 10.1211/jpp.61.04.0004 Jagle, 1950, Fluorometric determination of quinine in oily drugs, Rev Quim Farm, 15, 5 Salvadori, 1982, Dosage de la quinine dans le plasma et l’urine par chromatographie en phase liquide, Ann Biol Clin, 40, 667 Edstein, 1983, Quantification of quinine in human serum by high-performance liquid chromatography, J Chromatogr, 278, 445, 10.1016/S0378-4347(00)84807-0 Edstein, 1990, Simultaneous measurement of quinine and quinidine in human plasma, whole blood, and erythrocytes by high-performance liquid chromatography with fluorescence detection, Ther Drug Monit, 12, 493, 10.1097/00007691-199009000-00015 Ericsson, 1993, Reversed-phase high-performance liquid chromatography determination of quinine in plasma, whole blood, urine, and samples dried on filter paper, Ther Drug Monit, 15, 334, 10.1097/00007691-199308000-00012 Mihaly, 1987, High-performance liquid chromatographic analysis of quinine and its diastereoisomer quinidine, J Chromatogr, 415, 177, 10.1016/S0378-4347(00)83207-7 Galloway, 1990, A simple and rapid method for the estimation of quinine using reversed-phase high-performance liquid chromatography with UV detection, J Anal Toxicol, 14, 345, 10.1093/jat/14.6.345 Chmurzyński, 1997, High-performance liquid chromatographic determination of quinine in rat biological fluids, J Chromatogr B Biomed Sci Appl., 693, 423, 10.1016/S0378-4347(97)00074-1 Hodel, 2009, A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma, J Chromatogr B Analyt Technol Biomed Life Sci, 877, 867, 10.1016/j.jchromb.2009.02.006 Le Guellec, 2009, Méthodologie pour l’évaluation du niveau de preuve du suivi thérapeutique pharmacologique, La Lettre du Pharmacologue, 23, 21